(FY)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -5.46M | -244.26%-3.72M | 507.12%2.43M | 239.32%3.03M | 93.20%-486.62K | -289.48K | 542.25%2.58M | 57.92%-596.52K | -207.71%-2.18M | -114.83%-7.15M |
Net income from continuing operations | ---29.31M | -45.73%-8.02M | -135.70%-10.44M | -528.15%-5.78M | -785.31%-18.61M | ---10.03M | -1,069.12%-5.5M | -437.31%-4.43M | 233.74%1.35M | 64.00%-2.1M |
Operating gains losses | --224.46K | ---- | ---- | ---- | 781.69%1.16M | --1.21M | ---- | ---- | ---- | -1,919.86%-170.9K |
Depreciation and amortization | --2.28M | 590.92%555.05K | 361.13%2.07M | 223.61%979.27K | 393.29%1.9M | --1.07M | 3,380.69%80.33K | 2,924.56%448.4K | 1,075.67%302.61K | 301.81%385.68K |
Unrealized gains and losses of investment securities | ---- | -136.26%-8.13K | --26.87K | ---2.71K | ---- | ---- | 260.13%22.43K | --0 | --0 | ---- |
Remuneration paid in stock | --193.44K | --185.35K | --0 | --0 | 95.07%106.73K | ---65.68K | --0 | --0 | 1,082.75%172.41K | -91.65%54.71K |
Deferred tax | ---1.44M | -123.02%-77.89K | 116.92%88.28K | 26.59%258.51K | 205.66%1.72M | --1.69M | --338.44K | ---521.66K | --204.21K | 2,051.49%561.12K |
Other non cashItems | --1.21M | -88.29%147.77K | -54.80%59.18K | -64.92%114.3K | 660.60%842.21K | ---876.98K | 2,101.10%1.26M | 2,174.22%130.93K | 392.14%325.83K | 7.04%110.73K |
Change In working capital | --21.38M | -45.16%3.52M | 181.46%10.63M | 264.71%7.47M | 306.72%12.39M | --6.72M | 4,262.19%6.42M | 786.83%3.78M | -2,222.53%-4.53M | -466.67%-5.99M |
-Change in receivables | --879K | -120.39%-517.13K | 15.16%4.72M | -641.83%-2.5M | 118.41%1.65M | ---5.45M | 8,550.21%2.54M | 6,893.30%4.1M | 655.21%461.35K | -15,957.92%-8.97M |
-Change in inventory | --681.25K | -192.80%-256.61K | 125.07%160.7K | -59.02%143.25K | -170.62%-210.58K | ---195.71K | --276.53K | ---640.99K | --349.58K | --298.19K |
-Change in prepaid assets | --358.29K | 16.29%-191.87K | 854.45%1.29M | 66.38%-507.44K | -2,411.49%-349.83K | --1.25M | -3,791.05%-229.2K | 202.36%135.18K | -21,484.10%-1.51M | 74.70%-13.93K |
-Change in payables and accrued expense | --19.59M | 48.66%4.45M | 4,152.54%4.41M | 2,209.60%10.39M | 411.31%14.2M | --10.65M | 1,675.63%2.99M | 115.87%103.7K | 48.20%449.97K | 59.04%2.78M |
-Change in other working capital | ---127.58K | -95.14%41.19K | -39.17%47.37K | 98.52%-63.43K | -3,217.51%-2.9M | --463.94K | --846.7K | --77.87K | ---4.28M | ---87.27K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | ---5.46M | -244.26%-3.72M | 507.12%2.43M | 239.32%3.03M | 93.20%-486.62K | ---289.48K | 542.25%2.58M | 57.92%-596.52K | -207.71%-2.18M | -114.83%-7.15M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -835.79K | 94.58%-197.92K | -46.97%-3.12M | -366.74%-3.15M | -154.17%-7.06M | -608.34K | -371,682.56%-3.65M | -19,898.26%-2.12M | -2,195.17%-674.65K | 11,231.10%13.04M |
Net PPE purchase and sale | ---835.79K | 94.58%-197.92K | -46.97%-3.12M | -366.74%-3.15M | -154.17%-7.06M | ---608.34K | -371,682.56%-3.65M | -19,898.26%-2.12M | -2,195.17%-674.65K | 11,231.10%13.04M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---835.79K | 94.58%-197.92K | -46.97%-3.12M | -366.74%-3.15M | -154.17%-7.06M | ---608.34K | -371,682.56%-3.65M | -19,898.26%-2.12M | -2,195.17%-674.65K | 11,231.10%13.04M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 5.43M | 501.49%2.88M | 253.78%777.36K | 437.14%601.82K | -145.29%-1.71M | -309.26K | -829.19%-718.16K | -118.92%-505.5K | -1,753.00%-178.51K | -1.66%3.78M |
Net issuance payments of debt | --1.4M | 467.08%2.64M | 17.99%-414.57K | -326.64%-780.36K | -209.87%-1.72M | ---309.26K | -6,444.21%-718.16K | -226.53%-505.5K | -1,981.35%-182.91K | 110.76%1.56M |
Net common stock issuance | --4.17M | --247.11K | --1.22M | --1.45M | --0 | --0 | --0 | --0 | --0 | -23.14%2.39M |
Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.62%-960 |
Net other financing activities | ---136.98K | --0 | ---32.47K | -1,728.97%-71.74K | 102.54%4.4K | --0 | --0 | --0 | --4.4K | -90.99%-173.51K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --5.43M | 501.49%2.88M | 253.78%777.36K | 437.14%601.82K | -145.29%-1.71M | ---309.26K | -829.19%-718.16K | -118.92%-505.5K | -1,753.00%-178.51K | -1.66%3.78M |
Net cash flow | ||||||||||
Beginning cash position | --992.3K | -58.39%1.56M | -78.75%1.46M | -90.06%992.3K | 1,317.29%9.98M | --2.15M | 178.81%3.76M | 34,351.95%6.89M | 1,303.14%9.98M | 226.02%704.29K |
Current changes in cash | ---865.65K | 42.62%-1.03M | 102.62%84.48K | 116.03%485.72K | -195.87%-9.26M | ---1.21M | -172.69%-1.8M | -359.26%-3.23M | -305.91%-3.03M | 2,346.54%9.66M |
Effect of exchange rate changes | --10.07K | -100.69%-1.32K | -84.02%14.3K | 76.89%-13.61K | 170.80%270.01K | --49.14K | 223.47%190.24K | 27.43%89.51K | -206.89%-58.88K | -508.38%-381.38K |
End cash Position | --136.72K | -75.31%530.94K | -58.39%1.56M | -78.75%1.46M | -90.06%992.3K | --992.3K | 318.15%2.15M | 178.81%3.76M | 34,351.95%6.89M | 1,317.45%9.98M |
Free cash from | ---6.3M | -262.98%-3.91M | 73.63%-692.88K | 96.06%-116.1K | 26.13%-7.58M | ---928.2K | -85.43%-1.08M | -83.99%-2.63M | -299.58%-2.94M | -197.59%-10.26M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.